Completed OBSERVATIONAL NCT03900520

Pneumonia Research and Vaccine Impact League (PREVAIL)

Evaluating Pneumococcal Conjugate Vaccine (PCV) Impact on Pneumonia and Pneumococcal Carriage Outcomes in India in Children 1-35 Months in India: Pneumonia Research and Vaccine Impact League

Sponsor: Johns Hopkins Bloomberg School of Public Health

Conditions Pneumonia

Updated 12 times since 2019 Last updated: Oct 10, 2023 Started: Oct 13, 2020 Primary completion: Nov 18, 2022 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pneumonia, this trial is completed. The trial is conducted by Johns Hopkins Bloomberg School of Public Health and has accumulated 12 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2023 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Jul 2023 — Nov 2023 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Apr 2023 — Jul 2023 [monthly]

Recruiting

▶ Show 7 earlier versions

Feb 2023 — Apr 2023 [monthly]

Recruiting
Sep 2022 — Feb 2023 [monthly]

Recruiting
Dec 2021 — Sep 2022 [monthly]

Recruiting
Jan 2021 — Dec 2021 [monthly]

Recruiting
Dec 2020 — Jan 2021 [monthly]

Recruiting
Nov 2020 — Dec 2020 [monthly]

Recruiting
May 2019 — Nov 2020 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins Bloomberg School of Public Health
Maulana Azad Medical College
Pfizer

Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Delhi, India